Literature DB >> 10589771

Genetically fluorescent melanoma bone and organ metastasis models.

M Yang1, P Jiang, Z An, E Baranov, L Li, S Hasegawa, M Al-Tuwaijri, T Chishima, H Shimada, A R Moossa, R M Hoffman.   

Abstract

We report here the establishment and metastatic properties of bright, highly stable, green fluorescent protein (GFP) expression transductants of the B16 mouse malignant melanoma cell line and the LOX human melanoma line. The highly fluorescent malignant melanoma cell lines allowed the visualization of skeletal and multiorgan metastases after i.v. injection of B16 cells in C57BL/6 mice and intradermal injection of LOX cells in nude mice. The melanoma cell lines were transduced with the pLEIN expression retroviral vector containing the GFP and neomycin resistance genes. Stable B16F0 and LOX clones expressing high levels of GFP were selected stepwise in vitro in levels of G418 of up to 800 microg/ml. Extensive bone and bone marrow metastases of B16F0 were visualized by GFP expression when the animals were sacrificed 3 weeks after cell implantation. Metastases for both cell lines were visualized in many organs, including the brain, lung, pleural membrane, liver, kidney, adrenal gland, lymph nodes, skeleton, muscle, and skin by GFP fluorescence. This is the first observation of experimental skeletal metastases of melanoma, which was made possible by GFP expression. These models should facilitate future studies of the mechanism and therapy of bone and multiorgan metastasis of melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589771

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  26 in total

1.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases.

Authors:  M Yang; E Baranov; P Jiang; F X Sun; X M Li; L Li; S Hasegawa; M Bouvet; M Al-Tuwaijri; T Chishima; H Shimada; A R Moossa; S Penman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Establishment of green fluorescent protein-expressing hepatocellular carcinoma cell lines with different metastatic potential: relevant models for in vivo monitoring of metastasis and angiogenesis.

Authors:  Yang Xu; Hui-Chuan Sun; Bo Tian; Yan Li; Jie Chen; Jun Chen; Dong-Mei Gao; Qiong Xue; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

Review 3.  The biology of brain metastases-translation to new therapies.

Authors:  April F Eichler; Euiheon Chung; David P Kodack; Jay S Loeffler; Dai Fukumura; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2011-04-12       Impact factor: 66.675

4.  Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model.

Authors:  N C Lee; M Bouvet; S Nardin; P Jiang; E Baranov; B Rashidi; M Yang; X Wang; A R Moossa; R M Hoffma
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Melanoma brain metastases: an unmet challenge in the era of active therapy.

Authors:  Vikram Gorantla; John M Kirkwood; Hussein A Tawbi
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

6.  A color-coded orthotopic nude-mouse treatment model of brain-metastatic paralyzing spinal cord cancer that induces angiogenesis and neurogenesis.

Authors:  K Hayashi; K Yamauchi; N Yamamoto; H Tsuchiya; K Tomita; M Bouvet; J Wessels; R M Hoffman
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

7.  ADP-ribosylation factor 6 regulates tumorigenic and invasive properties in vivo.

Authors:  Vandhana Muralidharan-Chari; Holly Hoover; James Clancy; Jill Schweitzer; Mark A Suckow; Valerie Schroeder; Francis J Castellino; Jeffrey S Schorey; Crislyn D'Souza-Schorey
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

8.  MDA-MB-435 human breast carcinoma metastasis to bone.

Authors:  John F Harms; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Antimetastatic activity of MONCPT in preclinical melanoma mice model.

Authors:  Xiao-Chun Yang; Chong-Xing Tu; Pei-Hua Luo; Hong Zhu; Di-Feng Zhu; Hong-Hai Wu; Xing-Lu Zhou; Wei Lu; Qiao-Jun He; Bo Yang
Journal:  Invest New Drugs       Date:  2009-09-30       Impact factor: 3.850

Review 10.  Molecular imaging of metastatic potential.

Authors:  Paul T Winnard; Arvind P Pathak; Surajit Dhara; Steven Y Cho; Venu Raman; Martin G Pomper
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.